Randomized phase II study of the induction chemotherapy with docetaxel alone vs CDDP [cisplatin] + docetaxel for c-stage IB-II non-small lung cancer (JCOG 0204-MF).
Latest Information Update: 03 Nov 2021
Price :
$35 *
At a glance
- Drugs Docetaxel (Primary) ; Cisplatin
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 06 Jun 2010 5-year results presented at 46th Annual Meeting of the American Society of Clinical Oncology (ASCO).
- 14 Aug 2009 New source identified and integrated (University Hospital Medical Information Network - Japan).
- 09 Feb 2006 New trial record.